NVCT

Nuvectis Pharma, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Sanchez JuanDirector
$75k13k shares
BuyNov 5, 2025
$5.79
--
Kaplan Matthew L.Director
$64k11k shares
BuyNov 5, 2025
$5.84
--
Bentsur RonDirector, 10 Percent Owner, Officer: Chairman & CEO
$29k5k shares
BuyNov 5, 2025
$5.72
--
Mosseri Marlio Charles10 Percent Owner
$457k72.8k shares
BuyOct 27, 2025
$6.28
--
Mosseri Marlio Charles10 Percent Owner
$215k35k shares
BuyOct 24, 2025
$6.15
--
Mosseri Marlio Charles10 Percent Owner
$284k46.9k shares
BuyOct 23, 2025
$6.06
--

News

zacks.comWall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Betzacks.comMay 25globenewswire.comNuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQglobenewswire.comMay 14zacks.comWall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Tradezacks.comMay 7globenewswire.comNuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlightsglobenewswire.comMay 5globenewswire.comNuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meetingglobenewswire.comMar 31
NVCT smart money exposure | 交易笔记